Central action of low-molecular weight polyphloretin phosphate fraction in rats.
The central effects of a low-molecular weight fraction of polyphloretin phosphate (PPP) with molecular weight about 4600 were studied using several behavioural tests in animals (Lat's test, open-field test, hold-board test, irritability, spontaneous motor activity), chlorpromazine-induced catalepsy test, body temperature measurements, hexobarbital-induced sleep duration, reaction to thermal painful stimulus, measurements of arterial blood pressure, heart rate and respiratory rate. The activity of prostaglandin synthetase was determined also in the microsomes of bovine hypothalamic cells in vitro. Using some of the above tests the effect of PPP was studied on the central action of prostaglandins F2 alpha and E2 (PGF2 alpha and PGE2). PPP was administered intraventricularly (i.c.v.) in various doses (doses producing the lowest pharmacological effect in a given test) 10 minutes before i.c.v. administration of these prostaglandins in doses of 1 or 10 microgram. It was shown that PPP (low-molecular weight fraction) injected into the lateral cerebral ventricle of the rat exerted a biological effect on the central nervous system manifesting itself as behaviour changes in the tests used, and as changes of the arterial blood pressure. PPP i.c.v. antagonized certain central effects of PGF2 alpha and PGE2. The degree of inhibition of various prostaglandins differed in relation to the test used and was somewhat stronger in the case of PGF2 alpha.